Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Heitz

Showing results (81-90 of 178) with videos related to

Pageof 18
Sort By:
The Oncologist|June 10, 2017
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyFelicia T Roncolato, Florence Joly, Rachel O'Connell, et al.
Journal of Surgical Oncology|March 9, 2026
Fertility-Sparing Surgery, Treatment Strategies and Survival of Women With Malignant Ovarian Germ Cell Tumours-A Descriptive Analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie CORSETT DatabaseMaximilian Klar, Malak Moubarak, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2023
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrenceHelmut Plett, Enzo Ricciardi, Vlad Vacaru, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics DimensionsBoris Winterhoff, Stefan Kommoss, Florian Heitz, et al.
JCO Precision Oncology|June 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyMohamad Kayali, Eric Hahnen, Alexander Burges, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifierAmy Jamieson, Marcel Grube, Felix Kommoss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaboratorsDominik Denschlag, Florian Heitz, Jacobus Pfisterer, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Gynecologic Oncology|September 2, 2018
The genetic landscape of 87 ovarian germ cell tumorsEls Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, et al.
Pageof 18

Showing results (81-90 of 178) with videos related to

Sort By:
Pageof 18
The Oncologist|June 10, 2017
Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit StudyFelicia T Roncolato, Florence Joly, Rachel O'Connell, et al.
Journal of Surgical Oncology|March 9, 2026
Fertility-Sparing Surgery, Treatment Strategies and Survival of Women With Malignant Ovarian Germ Cell Tumours-A Descriptive Analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie CORSETT DatabaseMaximilian Klar, Malak Moubarak, Philipp Harter, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 9, 2023
Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrenceHelmut Plett, Enzo Ricciardi, Vlad Vacaru, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|March 1, 2019
Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics DimensionsBoris Winterhoff, Stefan Kommoss, Florian Heitz, et al.
JCO Precision Oncology|June 12, 2026
Constitutional <i>BRCA1</i> Promoter Methylation in Patients With Ovarian Cancer: Results of the Observational AGO-TR1 StudyMohamad Kayali, Eric Hahnen, Alexander Burges, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Validation and clinical performance of a single test, DNA based endometrial cancer molecular classifierAmy Jamieson, Marcel Grube, Felix Kommoss, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Impact of metformin, statins, and beta blockers on survival in patients with primary ovarian cancer: combined analysis of four prospective trials of AGO-OVAR and ENGOT/GCIG collaboratorsDominik Denschlag, Florian Heitz, Jacobus Pfisterer, et al.
Gynecologic Oncology|June 23, 2022
Predictive biomarker for surgical outcome in patients with advanced primary high-grade serous ovarian cancer. Are we there yet? An analysis of the prospective biobank for ovarian cancerCarlotta Keunecke, Hagen Kulbe, Felix Dreher, et al.
Gynecologic Oncology|September 2, 2018
The genetic landscape of 87 ovarian germ cell tumorsEls Van Nieuwenhuysen, Pieter Busschaert, Patrick Neven, et al.
Pageof 18